The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
Opiate Antagonists for Chronic Pain: A Review on the Benefits of Low-Dose Naltrexone in Arthritis versus Non-Arthritic Diseases
Biomedicines
02 June 2023
https://pubmed.ncbi.nlm.nih.gov/37371715/
Pilot Study of Low-Dose Naltrexone for the Treatment of Chronic Pain Due to Arthritis: A Randomized, Double-blind, Placebo-Controlled, Crossover Clinical Trial
Clin Ther
10 April 2023
https://pubmed.ncbi.nlm.nih.gov/37045708/
Marilyn - US: RA Pain (LDN; low dose naltrexone)
Natasha - Australia: Chronic Pain and Cancer (LDN; low dose naltrexone)
‘Promising Results’ for Low-Dose Naltrexone as Pain Reliever
Pain News Network
15 November 2022
https://www.painnewsnetwork.org/stories/2022/11/15/promising-results-for-low-dose-naltrexone-as-pain-reliever
Low-Dose Naltrexone Promising for pain relief in fibromyalgia and host of chronic conditions
Medical Dialogues
15 November 2022
https://medicaldialogues.in/medicine/news/low-dose-naltrexone-promising-for-pain-relief-in-fibromyalgia-and-host-of-chronic-conditions-102374
Linda Elsegood: Welcome to the LDN radio show brought to you by the LDN Research Trust I'm your host, Linda Elsegood. I have an exciting lineup of guest speakers who are LDN experts in their field. We will be discussing low-dose naltrexone and its many uses in autoimmune diseases, cancers, etc. Thank you for joining us.
Linda: Welcome to the LDN radio show brought to you by the LDN Research Trust. I'm your host Linda Elsegood. I have an exciting lineup of guest speakers who are LDN experts in their field. We will be discussing low dose naltrexone and its many uses in autoimmune diseases, cancers, etc. Thank you for joining us.